CSTL
Price
$33.19
Change
-$1.18 (-3.43%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.05B
14 days until earnings call
Intraday BUY SELL Signals
GH
Price
$162.98
Change
-$3.68 (-2.21%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
22.37B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs GH

CSTL vs GH Comparison Chart in %
View a ticker or compare two or three
VS
CSTL vs. GH commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Hold and GH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSTL with price predictions
Oct 21, 2026

Momentum Indicator for CSTL turns positive, indicating new upward trend

CSTL saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 80 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 54 cases where CSTL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

CSTL moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 228 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

CSTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 198 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Bearish Trend Analysis

The 10-day RSI Indicator for CSTL moved out of overbought territory on September 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 28 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 30 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (64.450). P/E Ratio (-53.703) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for GH with price predictions
Oct 21, 2026

GH in upward trend: price may jump up because it broke its lower Bollinger Band on October 08, 2026

GH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 39 cases where GH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 51 cases where GH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +5.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where GH advanced for three days, in 241 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 175 of 210 cases where GH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The 10-day RSI Indicator for GH moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 26 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GH as a result. In 66 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for GH turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 33 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

GH moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GH crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-100.352) is normal, around the industry mean (64.450). P/E Ratio (-47.481) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (19.120) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. GH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
CSTL vs GH: Fundamental Ratings
CSTL
GH
OUTLOOK RATING
1..100
4189
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10078
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
8556
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (13) in the Medical Or Nursing Services industry is in the same range as CSTL (22) in the null industry. This means that GH’s stock grew similarly to CSTL’s over the last 12 months.

GH's Profit vs Risk Rating (78) in the Medical Or Nursing Services industry is in the same range as CSTL (100) in the null industry. This means that GH’s stock grew similarly to CSTL’s over the last 12 months.

CSTL's SMR Rating (92) in the null industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (36) in the Medical Or Nursing Services industry is in the same range as CSTL (38) in the null industry. This means that GH’s stock grew similarly to CSTL’s over the last 12 months.

GH's P/E Growth Rating (56) in the Medical Or Nursing Services industry is in the same range as CSTL (85) in the null industry. This means that GH’s stock grew similarly to CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLGH
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (CSTL: $34.37 vs. GH: $166.66)
Brand notoriety: CSTL: Not notable vs. GH: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 99% vs. GH: 143%
Market capitalization -- CSTL: $1.05B vs. GH: $22.37B
CSTL [@Medical Specialties] is valued at $1.05B. GH’s [@Medical Specialties] market capitalization is $22.37B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 1 FA rating(s) are green while GH’s FA Score has 1 green FA rating(s).

  • CSTL’s FA Score: 1 green, 4 red.
  • GH’s FA Score: 1 green, 4 red.
According to our system of comparison, GH is a better buy in the long-term than CSTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 6 TA indicator(s) are bullish while GH’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 6 bullish, 4 bearish.
  • GH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than GH.

Price Growth

CSTL (@Medical Specialties) experienced а +3.81% price change this week, while GH (@Medical Specialties) price change was +2.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.66%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was +41.88%.

Reported Earning Dates

CSTL is expected to report earnings on Nov 05, 2026.

GH is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-3.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
CSTL
Daily Signal:
Gain/Loss:
GH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+3.68%
TCMD - CSTL
50%
Loosely correlated
-1.02%
NEO - CSTL
47%
Loosely correlated
+2.53%
GH - CSTL
44%
Loosely correlated
+2.50%
ADPT - CSTL
44%
Loosely correlated
+3.73%
NTRA - CSTL
40%
Loosely correlated
+1.84%
More

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with NTRA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+2.50%
NTRA - GH
51%
Loosely correlated
+1.84%
ADPT - GH
47%
Loosely correlated
+3.73%
PSNL - GH
46%
Loosely correlated
-0.25%
CSTL - GH
43%
Loosely correlated
+3.68%
RGEN - GH
42%
Loosely correlated
+0.63%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESEA68.871.56
+2.32%
Euroseas Ltd
ACRV1.830.03
+1.67%
Acrivon Therapeutics
APAM33.130.17
+0.52%
Artisan Partners Asset Management
AR38.51-0.32
-0.82%
ANTERO RESOURCES Corp
SGLY0.45-0.04
-7.71%
Singularity Future Technology Ltd